Table 2 Use of imaging amongst the 217 participants across the 12-month study period, stratified by imaging type and time-period (n, %, 95%CI)
Any imaging type | First report of any imaging | X-ray | CT | MRI | Other* | |
|---|---|---|---|---|---|---|
Any imaging | 132, 60.8, 54.0-67.4 | Not applicable | 97, 44.7, 37.0-51.6 | 67, 30.8, 24.9–37.6 | 30, 13.82, 9.7–19.3 | 32, 14.8, 10.5–20.3 |
Baseline | 52, 23.7, 18.4–30.2 | 52, 23.7, 18.4–30.2 | 40, 18.4, 13.8–24.1 | 24, 11.1, 7.5–15.9 | 14, 6.5, 3.9–10.5 | 12, 5.5, 3.2–9.4 |
2-weeks | 13, 6.0, 3.2–10.0 | 9, 4.1, 2.0–8.0 | 9, 4.1, 2.2–7.7 | 1, 0.5, 0.1–2.6 | 1, 0.5, 0.1–2.6 | 2, 0.9, 0.3–3.3 |
6-weeks | 19, 8.8, 5.3–13.3 | 8, 3.7, 1.7–7.4 | 11, 5.1, 2.9–8.8 | 2, 0.9, 0.3–3.3 | 4, 1.8, 0.7–4.6 | 4, 1.8, 0.7–4.6 |
3-months | 10, 4.5, 2.2–8.3 | 6, 2.8, 1.1–6.2 | 4, 1.8, 0.7–4.6 | 3, 1.4, 0.5-4.0 | 4, 1.8, 0.7–4.6 | 1, 0.5, 0.1–2.6 |
6-months | 68, 31.1, 25.2–37.9 | 49, 22.6, 17.3–28.8 | 40, 18.4, 13.8–24.1 | 37, 17.1, 12.6–22.6 | 7, 3.2, 1.6–6.5 | 11, 5.1, 2.9–8.8 |
9-months | 16, 7.4, 4.3–11.7 | 4, 1.8, 0.6-5.0 | 9, 4.1, 2.2–7.7 | 7, 3.2, 1.6–6.5 | 4, 1.8, 0.7–4.6 | 3, 1.4, 0.5-4.0 |
12-months | 15, 6.9, 3.9–11.1 | 4, 1.8,0.6-5.0 | 6, 2.8, 1.3–5.9 | 7, 3.2, 1.6–6.5 | 2, 0.9, 0.3–3.3 | 6, 2.8, 1.3–5.9 |